Multiple myeloma is a type of cancer that affects plasma cells, which are a crucial part of the immune system. Plasma cells are responsible for producing antibodies that help fight off infections and diseases. In multiple myeloma, these plasma cells become cancerous and multiply uncontrollably, crowding out healthy cells in the bone marrow.
The exact cause of multiple myeloma is unknown, but certain risk factors such as age, family history, and exposure to certain chemicals or radiation may increase the likelihood of developing the disease. Symptoms of multiple myeloma can vary but commonly include bone pain, fatigue, frequent infections, and anemia.
Diagnosis of multiple myeloma involves various tests, including blood and urine tests, bone marrow biopsy, and imaging scans. Treatment options depend on the stage and severity of the disease but may include chemotherapy, targeted therapy, stem cell transplant, and radiation therapy.
Early detection and prompt treatment are crucial for managing multiple myeloma and improving outcomes. While there is currently no cure for multiple myeloma, advancements in treatment have significantly improved survival rates and quality of life for patients.